<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE nitf SYSTEM "http://www.nitf.org/IPTC/NITF/3.3/specification/dtd/nitf-3-3.dtd">
<nitf change.date="June 10, 2005" change.time="19:30" version="-//IPTC//DTD NITF 3.3//EN">
  <head>
    <title>Prostate Test and More</title>
    <meta content="LTR224406" name="slug"/>
    <meta content="9" name="publication_day_of_month"/>
    <meta content="5" name="publication_month"/>
    <meta content="2000" name="publication_year"/>
    <meta content="Tuesday" name="publication_day_of_week"/>
    <meta content="Science Desk" name="dsk"/>
    <meta content="3" name="print_page_number"/>
    <meta content="F" name="print_section"/>
    <meta content="5" name="print_column"/>
    <meta content="Science; Opinion" name="online_sections"/>
    <docdata>
      <doc-id id-string="1198161"/>
      <doc.copyright holder="The New York Times" year="2000"/>
      <identified-content>
        <classifier class="indexing_service" type="descriptor">Cancer</classifier>
        <classifier class="indexing_service" type="descriptor">Prostate Gland</classifier>
        <classifier class="indexing_service" type="descriptor">Tests and Testing</classifier>
        <classifier class="indexing_service" type="descriptor">Men</classifier>
        <person class="indexing_service">machlowitz, roy a</person>
        <classifier class="online_producer" type="types_of_material">Letter</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/News/Science</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion</classifier>
        <classifier class="online_producer" type="taxonomic_classifier">Top/Opinion/Opinion</classifier>
        <classifier class="online_producer" type="general_descriptor">Men</classifier>
        <classifier class="online_producer" type="general_descriptor">Cancer</classifier>
        <classifier class="online_producer" type="general_descriptor">Prostate Gland</classifier>
        <classifier class="online_producer" type="general_descriptor">Tests and Testing</classifier>
        <classifier class="online_producer" type="general_descriptor">Diseases and Conditions</classifier>
        <classifier class="online_producer" type="general_descriptor">Medicine and Health</classifier>
      </identified-content>
    </docdata>
    <pubdata date.publication="20000509T000000" ex-ref="http://query.nytimes.com/gst/fullpage.html?res=9A07E0D71038F93AA35756C0A9669C8B63" item-length="139" name="The New York Times" unit-of-measure="word"/>
  </head>
  <body>
    <body.head>
      <hedline>
        <hl1>Prostate Test and More</hl1>
      </hedline>
      <abstract>
        <p>Roy A Machlowitz letter on May 2 article calls for more and improved screening of men over 50 for prostate cancer</p>
      </abstract>
    </body.head>
    <body.content>
      <block class="lead_paragraph">
        <p>To the Editor:</p>
        <p>Re ''Findings Fuel Debate on Prostate Test'' (May 2):</p>
        <p>Urologists over 50 who oppose the prostate-specific antigen, or P.S.A., screening of men over 50 while undoubtedly having annual tests themselves are not only hypocritical but denying their patients the best available means of early detection of this deadly form of cancer in males.</p>
      </block>
      <block class="full_text">
        <p>To the Editor:</p>
        <p>Re ''Findings Fuel Debate on Prostate Test'' (May 2):</p>
        <p>Urologists over 50 who oppose the prostate-specific antigen, or P.S.A., screening of men over 50 while undoubtedly having annual tests themselves are not only hypocritical but denying their patients the best available means of early detection of this deadly form of cancer in males.</p>
        <p>Still, efforts should be devoted to developing a more accurate screening procedure, one that would avoid the unnecessary painful and costly biopsies, which also have inherent errors.</p>
        <p>ROY  A. MACHLOWITZ  Glenside, Pa.</p>
      </block>
    </body.content>
  </body>
</nitf>
